Analysts have recently evaluated Madrigal Pharmaceuticals and provided 12-month price targets. The average target is $497.5, accompanied by a high estimate of $554.00 and a low estimate of $428.00.

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second-quarter 2025 investor letter ...

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has been approved in Europe for the treatment of metabolic ...

Vanderpump Rules' star Scheana Shay is reacting to Peter Madrigal saying that he doesn't like the former members of the show.

Defining workplace culture, elevating customer service and strengthening collaboration have been the name of the game for ...

Hasan Minhaj, George Lopez to star in an all-immigrant cast virtual table read of “Superbad," benefiting Immigrant Defenders ...

Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

New York; Tuesday, 7:10 p.m. EDT PITCHING PROBABLES: Phillies: Jesus Luzardo (12-6, 4.10 ERA, 1.30 WHIP, 170 strikeouts); Mets: Sean Manaea (1-2, 5.15 ERA, 1.12 WHIP, 45 strikeouts) BETMGM SPORTSBOOK ...

A true Austin institution since 1946, Sandy's Hamburgers is more than just a burger joint – it's a haven for classic frozen ...

BOTTOM LINE: The New York Mets will look to sweep a three-game series with a win against the Atlanta Braves. Atlanta has a 32 ...

Highlights,Madrigal Pharmaceuticals shows strong share movement in recent weeks,Revenue growth remains uneven across short- ...

Nevada comes into the 2025 season looking to improve and surprise some, but they will still be a massive underdog against ...